Skip to main navigation Skip to search Skip to main content

Early safety, immune monitoring, and efficacy results from three patients enrolled in a Phase 2 trial of TGFÃŽÂ 2 RI inhibitor, LY2157299, with neoadjuvant 5-fluorouracil and radiation in patients with locally advanced rectal cancer

  • Y. Koguchi
  • , M. Phillips
  • , K. McCarty
  • , Y.Y. To
  • , D. Devine
  • , W.L. Redmond
  • , M. Gough
  • , M.R. Crittenden
  • , K.H. Young

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalInternational Journal of Radiation Oncology Biology Physics
Volume99
DOIs
StatePublished - Oct 1 2017

Disciplines

  • Medicine and Health Sciences
  • Radiology

Cite this